Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.

Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.

http://www.wikidata.org/entity/Q37071108

about

Targeting the leukemia-stroma interaction in acute myeloid leukemia: rationale and latest evidence A hostel for the hostile: the bone marrow niche in hematologic neoplasms The increased expression of integrin α6 (ITGA6) enhances drug resistance in EVI1(high) leukemia High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group Functional and structural insights into ASB2alpha, a novel regulator of integrin-dependent adhesion of hematopoietic cells High VLA-4 expression is associated with adverse outcome and distinct gene expression changes in childhood B-cell precursor acute lymphoblastic leukemia at first relapse.Performance status in elderly patients with acute myeloid leukemia: exploring gene expression signatures of cytokines and chemokines.Retrovirus-transformed erythroleukemia cells induce central nervous system failure in a new syngeneic mouse model of meningeal leukemia.Breaking and entering into the CNS: clues from solid tumor and nonmalignant models with relevance to hematopoietic malignancies.Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group A phase 1/2 study of chemosensitization with the CXCR4 antagonist plerixafor in relapsed or refractory acute myeloid leukemia The regulation of normal and leukemic hematopoietic stem cells by niches.Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy.Significance of expression of ITGA5 and its splice variants in acute myeloid leukemia: a report from the Children's Oncology Group.Role of leukemia cell invadosome in extramedullary infiltration.The role of natalizumab in hematopoietic stem cell mobilization.Targeting the microenvironment in acute myeloid leukemia.Myeloid malignancies and the microenvironment.VLA-4 and CXCR4 expression levels show contrasting prognostic impact (favorable and unfavorable, respectively) in acute myeloid leukemia.Targeting myelogenous leukemia stem cells: role of the circulation.The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia.Therapeutic Antibodies for Myeloid Neoplasms-Current Developments and Future Directions.Dependence of acute myeloid leukemia on adhesion within the bone marrow microenvironment.

P2860

Q26770388-24F30B7A-30C0-47FA-ACD0-EE7C2E36841A Q26777629-0C8666C8-3C09-4EFC-8648-80651F2CEEB1 Q28479144-BF6B34AC-93E4-4FEF-A9AD-B2F2C5075856 Q33990843-50AF6D52-025A-4A16-9857-4BF9684FC7DD Q35182907-3F15527C-6421-472C-BB25-00B54FB23A85 Q35528643-87D14E90-2BB1-4828-A99C-C98A743BC097 Q35661799-39492F71-DA56-4A97-B513-6D7405FD8B43 Q35690746-1CD2DB30-5ACD-4128-B47D-DCE0BC15482A Q35786301-7EA00566-5B21-4D62-AE0B-8CA8FCCD973D Q35862717-C252BE4F-7078-4122-ADB4-4D4208C899D3 Q35953355-A48363C4-708D-47A6-A934-5C5E83A8C1E1 Q36284911-236CF6A1-95B7-41FD-ABC9-36DD485EE054 Q36666787-1B6AF4A5-8F2D-4236-9B97-59663C7A95B4 Q37131922-DA1E97AF-CC4F-4021-985A-272E4D920FE0 Q37373047-B03B97E9-73D8-4AE6-A3E2-7B8F7FB3F8F8 Q37536053-34C550FA-F4B3-4C6C-A42E-5AB078AAFB79 Q38447268-C2364165-1F32-4DC9-946D-86608CC45426 Q39073878-642BAF5F-80B1-4437-8DD2-4F649DB327F6 Q41602417-45372747-AA6D-43A9-8EF8-2717C47E192E Q41860215-04540D4F-95DA-4FE3-B4EB-8D1F5E72D03B Q49176545-AC6E6A49-06E5-4E57-A4D4-D053952C987A Q55354182-E572DD06-CF73-4294-9353-631986B0177C Q55712500-B08E682F-553D-4C97-968F-3756681AD2DC

P2860

Very late antigen-4 function of myeloblasts correlates with improved overall survival for patients with acute myeloid leukemia.

http://www.wikidata.org/entity/Q37071108

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 16 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Very late antigen-4 function o ...... s with acute myeloid leukemia.

@en

Very late antigen-4 function o ...... s with acute myeloid leukemia.

@nl

type

label

Very late antigen-4 function o ...... s with acute myeloid leukemia.

@en

Very late antigen-4 function o ...... s with acute myeloid leukemia.

@nl

prefLabel

Very late antigen-4 function o ...... s with acute myeloid leukemia.

@en

Very late antigen-4 function o ...... s with acute myeloid leukemia.

@nl

P1433

Q37071108-EAE0EF56-5D15-432A-8120-5A2CC36D49E5

P1476

Q37071108-4E644B89-EF02-4E77-AFE0-1004C09076CD

P2093

Q37071108-083F4F39-687E-40A3-9731-34171DC52F58

Q37071108-0BBC25DA-84E2-45D2-BB4F-B889C0C20592

Q37071108-1BD713D4-AC75-4F0A-A947-4169EBD1EA50

Q37071108-3777542F-19B6-4880-BD0E-F57E839F9AD7

Q37071108-785A2965-133B-40F3-B4E0-0ACE87416C32

Q37071108-8E7C7638-1EEC-4E51-A1CB-B5749BC52E78

Q37071108-AE53FD73-5647-4811-8585-4D6E12467A74

Q37071108-D9D655F9-D63F-4756-BBAF-9054B33B6C75

P2860

Q37071108-2ECF13B7-E1F6-4808-B77C-58E04DD4F9E4

Q37071108-3A4B9BBF-0E6C-4DCB-85A8-3234E8AECEA2

Q37071108-47C3BE51-68AC-465E-9F06-BF44AFE94E2B

Q37071108-5A71B86E-507C-4C9F-B80C-F654CFB7A34F

Q37071108-5E096F89-CE04-4847-A2AA-B6E547E1F531

Q37071108-72AC90EE-2AD6-44B0-83AF-3D0241D65E42

Q37071108-74101C9D-8003-4E94-9158-3358229E11EB

Q37071108-7B5B4D8E-9253-4CB5-8F74-D02411A31859

Q37071108-81BAB42B-2D9B-4BF0-85E8-631C3DDFD970

Q37071108-81FBF97E-9AF9-4F72-8A7A-4345512F5BD5

P304

Q37071108-87EAC63C-9BED-4B66-9AA3-342711522824

P31

Q37071108-DD812383-8E0A-4943-A3E4-0CBB560D8FB9

P356

Q37071108-C96C2D5E-2D4D-42B7-993A-E55CC24E842E

P407

Q37071108-B5EBC94E-A86A-4B37-A353-1E3D51EC6F4A

P433

Q37071108-E00E219D-B01E-46C2-BEFB-FA08511A9DC2

P478

Q37071108-5568D006-D551-4672-9C5F-C9C8B11BE05C

P50

Q37071108-016FDD95-8EDE-4C9F-B7F8-5E40FED1C2C6

Q37071108-60DB6869-6E96-4BA3-A82F-542A3D5F363B

P577

Q37071108-74C174DE-C440-4CCE-8842-FFD0EB8AD93E

P5875

Q37071108-7130AB5F-ECF2-4FBC-8D82-EABDFD7E70EC

P698

Q37071108-E408EB83-905F-4B5D-81F4-08F69D9A0AEE

P921

Q37071108-B446148B-F355-45E4-87C7-B3001AC24FB9

P932

Q37071108-5A06A343-7492-407B-BD69-B1287F840493

P356

BLOOD-2007-12-124818

P1433

P1476

Very late antigen-4 function o ...... s with acute myeloid leukemia.

@en

P2093

Adrianne N Wilks

http://www.w3.org/2001/XMLSchema#string

Cheryl L Willman

http://www.w3.org/2001/XMLSchema#string

Derek L Stirewalt

http://www.w3.org/2001/XMLSchema#string

John M Harlan

http://www.w3.org/2001/XMLSchema#string

Kenneth J Kopecky

http://www.w3.org/2001/XMLSchema#string

Pamela S Becker

http://www.w3.org/2001/XMLSchema#string

Sylvia Chien

http://www.w3.org/2001/XMLSchema#string

Thalia Papayannopoulou

http://www.w3.org/2001/XMLSchema#string

P2860

Mutant FLT3 signaling contributes to a block in myeloid differentiation

A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study

A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031).

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study.

Age and acute myeloid leukemia.

Size of FLT3 internal tandem duplication has prognostic significance in patients with acute myeloid leukemia.

PLZF-mediated control on VLA-4 expression in normal and leukemic myeloid cells.

Targeting of CD44 eradicates human acute myeloid leukemic stem cells.

Relation between CXCR-4 expression, Flt3 mutations, and unfavorable prognosis of adult acute myeloid leukemia.

Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).

P304

866-874

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2007-12-124818

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

113

http://www.w3.org/2001/XMLSchema#string

P50

Frederick R. Appelbaum

Stephen H Petersdorf

P577

2008-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23389219

http://www.w3.org/2001/XMLSchema#string

P698

18927435

http://www.w3.org/2001/XMLSchema#string

P921

P932

2630271

http://www.w3.org/2001/XMLSchema#string